Search result for 'amgen'

Biocon Biologics settles with Amgen to commercialize Denosumab biosimilars (Vevzuo & Evfraxy) in Europe starting Dec 2, 2025.

Biocon inks deal with Amgen to market Bosaya & Aukelso biosimilars (Prolia & Xgeva copies) in the US from Oct 2025.

Amgen inaugurates its new Technology and Innovation center in Hyderabad, investing USD 200 million this year. The center will create job opportunities in the biopharma sector.

Amazon.com Inc. joins the Dow Jones Industrial Average, replacing Walgreens Boots Alliance. Learn why Amazon is in and Walgreens is out and how it affects investors.